1,075 results on '"E, Campo"'
Search Results
2. P1295: DECIPHERING THE ROLE OF MSI2 AS A REGULATOR OF MANTLE CELL LYMPHOMA STEM-LIKE PROPERTIES
- Author
-
M. Sureda-Gómez, P. Balsas, M.-L. Rodríguez, F. Nadeu, A. De Bolòs, Á. Eguileor, M. Kulis, G. Castellano, E. Giné, S. Demajo, J. I. Martín-Subero, P. Jares, E. Campo, and V. Amador
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
3. PB2088: IMMUNE PROFILE OF PATIENTS WITH FOLLICULAR LYMPHOMA ASSESSED BY FLOW CYTOMETRY IN PERIPHERAL BLOOD: CHARACTERISTICS AT DIAGNOSIS AND AT RELAPSE OF THE DISEASE
- Author
-
A. Rivero Arango, P. Mozas, J. Correa, A. Rivas-Delgado, F. Araujo-Ayala, K. Guinetti, A. Bataller, M. Condom, A. Gaya, J. Delgado, E. Giné, P. Perez-Galán, E. Campo, A. Vlagea, E. Matutes, A. López-Guillermo, N. Villamor, and L. Magnano
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
4. P1277: MUTATIONAL LANDSCAPE AND COPY NUMBER ALTERATIONS IN TESTICULAR LARGE B-CELL LYMPHOMA
- Author
-
C. López, A. Rivas-Delgado, F. Nadeu, M. Grau, A. Rivero, J. Boschs-Schips, M. Alcoceba, G. Tapia, L. Luizaga, C. Bárcena, N. Kelleher, M. Pablo, O. Balague, G. Frigola, N. Villamor, L. Magnano, T. Baumann, A. Muntañola, J. M. Sancho-Cia, A. M. García-Sancho, E. Gonzalez Barca, F. Climent, E. Campo, E. Giné, A. López-Guillermo, and S. Beà
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
5. P631: A PCR-BASED ASSAY FOR IGLV3-21R110 SCREENING CONFIRMS ITS PROGNOSTIC VALUE IN AN INDEPENDENT COHORT OF 613 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
- Author
-
C. Syrykh, N. Russiñol, T. Baumann, M. Kulis, M. Alcoceba, M. González, E. Colado, Á. R. Payer, M. Aymerich, M. J. Terol, S. Ruiz-Gaspà, A. López-Guillermo, J. I. Martín-Subero, D. Colomer, J. Delgado, E. Campo, and F. Nadeu
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
6. P1282: DISEASE-SPECIFIC U1 SPLICEOSOMAL RNA MUTATIONS IN MATURE B-CELL NEOPLASMS
- Author
-
F. Nadeu, S. Shuai, G. Clot, L. K. Hilton, A. Diaz-Navarro, S. Martín, R. Royo, T. Baumann, M. Kulis, I. López-Oreja, M. Cossio, J. Lu, V. Ljungström, E. Young, K. Plevova, B. A. Knisbacher, Z. Lin, C. K. Hahn, P. Bousquets, M. Alcoceba, M. González, E. Colado, M. Aymerich, M. J. Terol, A. Rivas-Delgado, A. Enjuanes, S. Ruiz-Gaspà, T. Chatzikonstantinou, D. Hägerstrand, C. Jylhä, A. Skaftason, L. Mansouri, K. Stranska, M. Doubek, E. J. van Gastel-Mol, Z. Davis, R. Walewska, L. Scarfò, L. Trentin, A. Visentin, S. A. Parikh, K. G. Rabe, R. Moia, M. Armand, D. Rossi, F. Davi, G. Gaidano, N. E. Kay, T. Shanafelt, P. Ghia, D. Oscier, A. W. Langerak, S. Beà, A. López-Guillermo, D. Neuberg, C. J. Wu, G. Getz, S. Pospisilova, K. Stamatopoulos, R. Rosenquist, W. Huber, T. Zenz, D. Colomer, J. I. Martín-Subero, J. Delgado, R. D. Morin, L. D. Stein, X. S. Puente, and E. Campo
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
7. P1260: UNRAVELING THE GENETICS OF TRANSFORMED SPLENIC MARGINAL ZONE LYMPHOMA
- Author
-
M. Grau, C. López, A. Navarro, G. Clot, F. Nadeu, G. Bastidas, M. Alcoceba, M. J. Baptista, M. Blanes, F. Climent, D. Colomer, D. Costa, E. Domingo-Domènech, P. Forcada, A. Enjuanes, L. Escoda, G. Frigola, E. Giné, M. Lopez-Guerra, A. Rivas-Delgado, L. Vicente-Folch, A. Wotherspoon, E. Campo, A. López-Guillermo, E. Matutes, and S. Beà
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
8. P633: ACTIVE CHROMATIN REGULATORY LANDSCAPE OF STEREOTYPED SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA REVEALS A DISTINCTIVE SIGNATURE IN SUBSET #8
- Author
-
M. Tsagiopoulou, V. Chapaprieta, N. Russiñol, N. Pechlivanis, N. Papakonstantinou, N. Stavroyianni, F. Psomopoulos, E. Campo, K. Stamatopoulos, and J. I. Martin-Subero
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
9. S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME
- Author
-
D. Noerenberg, F. Briest, C. Hennch, K. Yoshida, J. Nimo, R. Hablesreiter, Y. Takeuchi, D. Sasca, H. Ueno, L. Mansouri, Y. Inoue, L. Wiegand, A. M. Staiger, B. Casadei, M. Ziepert, F. Asmar, P. Korkolopoulou, M. Kirchner, P. Mertins, J. Weiner, E. Toth, T. Weber, A. Warth, T. Schneider, R.-M. Amini, W. Klapper, M. Hummel, V. Poeschel, G. Kanellis, A. Rosenwald, G. Held, E. Campo, K. Stamatopoulos, I. Anagnostopoulos, L. Bullinger, N. Goldschmidt, P. L. Zinzani, C. Bödor, R. Rosenquist, T. P. Vassilakopoulos, G. Ott, S. Ogawa, and F. Damm
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2022
- Full Text
- View/download PDF
10. Fires and their key drivers in Mexico
- Author
-
Laura E. Montoya, Rogelio O. Corona-Núñez, and Julio E. Campo
- Subjects
Ecology ,Forestry - Abstract
Background Despite the regional and global effects of biomass burning at national and pantropical scales, little effort has focused on determining the influence of climate and socioeconomic conditions on fire regimes in tropical regions. Aims We explored the climate and human factors that explain remotely sensed burnt area and fire abundance in Mexico. Methods We used MCD64A1 data and climate and socioeconomic metrics to understand factors explaining the variation in number of fires and burned area. Key results The largest burned area (41.9% of the total) occurred in temperate forests, grasslands and hydrophilic vegetation, with numerous fire events of medium relative size. The next most extensive burned area (38%) was observed in croplands, with numerous small-size fires. The third group (17.8%) occurred in tropical forests, which had the smallest and most frequent fires. Finally, a fourth group (11.9%) was composed of shrublands, which showed the largest fire sizes and lowest-frequency events. The variability of burned area was related to variations in temperature and precipitation, poverty index, altitude, and distance to water bodies. Conclusions and Implications Our analysis suggests that an assessment integrating climate, human and topographic metrics predicts burned area and may improve fire forecasting in Mexico landscapes.
- Published
- 2023
- Full Text
- View/download PDF
11. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis
- Author
-
Adonis Sfera, Carolina Osorio, Nyla Jafri, Eddie Lee Diaz, and Jose E. Campo Maldonado
- Subjects
SARS-CoV-2 ,cellular senescence ,angiotensin II ,prognosis ,critical illness ,immune checkpoint inhibitors ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Severe acute respiratory syndrome coronavirus 2 has spread rapidly around the globe. However, despite its high pathogenicity and transmissibility, the severity of the associated disease, COVID-19, varies widely. While the prognosis is favorable in most patients, critical illness, manifested by respiratory distress, thromboembolism, shock, and multi-organ failure, has been reported in about 5% of cases. Several studies have associated poor COVID-19 outcomes with the exhaustion of natural killer cells and cytotoxic T cells, lymphopenia, and elevated serum levels of D-dimer. In this article, we propose a common pathophysiological denominator for these negative prognostic markers, endogenous, angiotensin II toxicity. We hypothesize that, like in avian influenza, the outlook of COVID-19 is negatively correlated with the intracellular accumulation of angiotensin II promoted by the viral blockade of its degrading enzyme receptors. In this model, upregulated angiotensin II causes premature vascular senescence, leading to dysfunctional coagulation, and immunity. We further hypothesize that angiotensin II blockers and immune checkpoint inhibitors may be salutary for COVID-19 patients with critical illness by reversing both the clotting and immune defects (Graphical Abstract).
- Published
- 2020
- Full Text
- View/download PDF
12. Primary care and CMA (continuity between care levels)
- Author
-
E Campo Cimarras and JM Iturralde Iriso
- Subjects
General Medicine - Abstract
Resumen La transversalidad y la continuidad asistencial, mediante la comunicación interniveles son la base para mejorar la atención a los pacientes. La Atención Primaria constituye el principio y el final de todo proceso asistencial. La consulta de la Unidad de CMA debe procurar establecerse como de alta resolución y debe incluir la valoración de cirugía, anestesia y enfermería. En ella se debe confirmar el diagnóstico y la indicación quirúrgica, así como aplicar los criterios de selección de pacientes y procedimientos, el consentimiento informado. Igualmente se debe dar al paciente y familiar toda la información acerca del proceso ambulatorio y, en lo posible, la fecha aproximada de la intervención. El control postoperatorio inmediato y tardío es factible realizarlo desde la Atención Primaria.
- Published
- 2022
- Full Text
- View/download PDF
13. Climate and socioeconomic drivers of biomass burning and carbon emissions from fires in tropical dry forests: A Pantropical analysis
- Author
-
Rogelio O. Corona‐Núñez and Julio E. Campo
- Subjects
Global and Planetary Change ,Ecology ,Environmental Chemistry ,General Environmental Science - Abstract
Global burned area has declined by nearly one quarter between 1998 and 2015. Drylands contain a large proportion of these global fires but there are important differences within the drylands, for example, savannas and tropical dry forests (TDF). Savannas, a biome fire-prone and fire-adapted, have reduced the burned area, while the fire in the TDF is one of the most critical factors impacting biodiversity and carbon emissions. Moreover, under climate change scenarios TDF is expected to increase its current extent and raise the risk of fires. Despite regional and global scale effects, and the influence of this ecosystem on the global carbon cycle, little effort has been dedicated to studying the influence of climate (seasonality and extreme events) and socioeconomic conditions of fire regimen in TDF. Here we use the Global Fire Emissions Database and, climate and socioeconomic metrics to better understand long-term factors explaining the variation in burned area and biomass in TDF at Pantropical scale. On average, fires affected 1.4% of the total TDF' area (60,208 kmEl área global quemada se redujo en casi una cuarta parte entre 1998 y 2015. Los bosques secos contienen una gran proporción de esos incendios globales, pero existen diferencias importantes dentro de ellos, por ejemplo, las sabanas y los bosques secos tropicales (SBC). Las sabanas, son un bioma propenso y adaptado al fuego, y que en los últimos años han reducido su área quemada. Mientras que el fuego en la SBC es uno de los factores más críticos que impactan la biodiversidad y las emisiones de carbono. Además, bajo escenarios de cambio climático, se espera que la SBC aumente su extensión actual y aumente el riesgo de incendios. A pesar de los efectos a escala regional y global, y la influencia de este ecosistema en el ciclo global del carbono, se le ha dedicado poco esfuerzo a estudiar la influencia del clima (estacionalidad y eventos extremos) y las condiciones socioeconómicas del régimen de incendios. Aquí usamos la base de datos global de emisiones de incendios y métricas climáticas y socioeconómicas para comprender mejor los factores a largo plazo que explican la variación en el área quemada y la biomasa a escala Pantropical. En promedio, los incendios afectaron el 1,4% del área total de la SBC (60 208 km
- Published
- 2022
- Full Text
- View/download PDF
14. Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma
- Author
-
P. Balsas, A. Esteve-Arenys, J. Roldán, L. Jiménez, V. Rodríguez, J. G. Valero, A. Chamorro-Jorganes, R. Puig de la Bellacasa, J. Teixidó, A. Matas-Céspedes, A. Moros, A. Martínez, E. Campo, A. Sáez-Borderías, J. I. Borrell, P. Pérez-Galán, D. Colomer, and G. Roué
- Subjects
B-NHL ,Btk ,Lyn ,Syk ,Cell migration ,Mouse model ,Diseases of the blood and blood-forming organs ,RC633-647.5 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Pharmacological inhibition of B cell receptor (BCR) signaling has recently emerged as an effective approach in a wide range of B lymphoid neoplasms. However, despite promising clinical activity of the first Bruton’s kinase (Btk) and spleen tyrosine kinase (Syk) inhibitors, a small fraction of patients tend to develop progressive disease after initial response to these agents. Methods We evaluated the antitumor activity of IQS019, a new BCR kinase inhibitor with increased affinity for Btk, Syk, and Lck/Yes novel tyrosine kinase (Lyn), in a set of 34 B lymphoid cell lines and primary cultures, including samples with acquired resistance to the first-in-class Btk inhibitor ibrutinib. Safety and efficacy of the compound were then evaluated in two xenograft mouse models of B cell lymphoma. Results IQS019 simultaneously engaged a rapid and dose-dependent de-phosphorylation of both constitutive and IgM-activated Syk, Lyn, and Btk, leading to impaired cell proliferation, reduced CXCL12-dependent cell migration, and induction of caspase-dependent apoptosis. Accordingly, B cell lymphoma-bearing mice receiving IQS019 presented a reduced tumor outgrowth characterized by a decreased mitotic index and a lower infiltration of malignant cells in the spleen, in tight correlation with downregulation of phospho-Syk, phospho-Lyn, and phospho-Btk. More interestingly, IQS019 showed improved efficacy in vitro and in vivo when compared to the first-in-class Btk inhibitor ibrutinib, and was active in cells with acquired resistance to this latest. Conclusions These results define IQS019 as a potential drug candidate for a variety of B lymphoid neoplasms, including cases with acquired resistance to current BCR-targeting therapies.
- Published
- 2017
- Full Text
- View/download PDF
15. T cell landscape definition by multi-omics identifies Galectin-9 as novel immunotherapy target in chronic lymphocytic leukemia
- Author
-
L Llaó Cid, JKL Wong, I Fernandez Botana, Y Paul, M Wierz, A Flörchinger, S Gonder, G Pagano, M Chazotte, K Bestak, C Schifflers, M Iskar, T Roider, JP Mallm, A Cosma, DE Campton, E Gerhard-Hartmann, A Rosenwald, D Colomer, E Campo, D Schapiro, S Dietrich, P Lichter, E Moussay, J Paggetti, M Zapatka, and M Seiffert
- Abstract
Failure of immunotherapy after applying checkpoint inhibitors or CAR-T cells is linked to T cell exhaustion. Here, we explored the T cell landscape in chronic lymphocytic leukemia (CLL) by single-cell omics analyses of blood, bone marrow and lymph node samples of patients and spleen samples of a CLL mouse model. By single-cell RNA-sequencing, mass cytometry (CyTOF), and multiplex image analysis of tissue microarrays, we defined the spectrum of phenotypes and transcriptional programs of T cells and and their differentiation state trajectories. We identified disease-specific accumulation of distinct regulatory T cell subsets and T cells harboring an exhausted phenotype exclusively in the CLL lymph node tissue. Integration of TCR data revealed a clonal expansion of CD8+precursor exhausted T cells, suggesting their reactivity for CLL cells. Interactome analyses identified the TIM3 ligand Galectin-9 as novel immunoregulatory molecule in CLL. Blocking of Galectin-9 in CLL-bearing mice slowed down disease development and reduced the number of TIM3 expressing T cells. Galectin-9 expression correlated with shorter survival of CLL patients. Thus, Galectin-9 contributes to immune escape in CLL and represents a novel target for immunotherapy.
- Published
- 2022
- Full Text
- View/download PDF
16. Conceptualizing Space and Place
- Author
-
Juan E. Campo
- Abstract
This chapter traces the conceptual genealogies of religious space and place in the modern study of religion. It describes the spatial turn in the field inaugurated by Mircea Eliade and the Chicago History of Religions School, which provoked a revisionist trend, led by Jonathan Z. Smith. Although this turn relied upon the appropriation of ancient and indigenous constructions of spatial significance, its dialectical relationship between scholarly and native epistemologies of space countered earlier colonial discourses that displaced spatial ways of thought and action in favor of temporal ones. A parallel spatial turn in the social sciences and humanities led by Lefebvre, Harvey, Foucault and others—also a critical reaction to this displacement—emphasized modern and postmodern spacialities, but largely neglected religious ones. Nevertheless, it inspired the revitalization of the study of religious space by a new generation of scholars, leading to a second turn in the field of religious studies.
- Published
- 2022
- Full Text
- View/download PDF
17. Optimal release programs for dengue prevention using Aedes aegypti mosquitoes transinfected with wMel or wMelPop Wolbachia strains
- Author
-
Mikhail Svinin, Daiver Cardona-Salgado, Lilian S. Sepúlveda-Salcedo, Olga Vasilieva, and Doris E. Campo-Duarte
- Subjects
Population ,Mosquito population ,Population Replacement ,02 engineering and technology ,Aedes aegypti ,Dengue fever ,parasitic diseases ,0502 economics and business ,0202 electrical engineering, electronic engineering, information engineering ,Dengue transmission ,medicine ,education ,reproductive and urinary physiology ,education.field_of_study ,biology ,Applied Mathematics ,05 social sciences ,General Medicine ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,medicine.disease ,Virology ,Computational Mathematics ,Modeling and Simulation ,bacteria ,020201 artificial intelligence & image processing ,Wolbachia ,General Agricultural and Biological Sciences ,050203 business & management - Abstract
In this paper, we propose a dengue transmission model of SIR(S)-SI type that accounts for two sex-structured mosquito populations: the wild mosquitoes (males and females that are Wolbachia-free), and those deliberately infected with either wMel or wMelPop strain of Wolbachia. This epidemiological model has four possible outcomes: with or without Wolbachia and with or without dengue. To reach the desired outcome, with Wolbachia and without dengue, we employ the dynamic optimization approach and then design optimal programs for releasing Wolbachia-carrying male and female mosquitoes. Our discussion is focused on advantages and drawbacks of two Wolbachia strains, wMelPop and wMel, that are recommended for dengue prevention and control. On the one hand, the wMel strain guarantees a faster population replacement, ensures durable Wolbachia persistence in the wild mosquito population, and requiters fewer releases. On the other hand, the wMelPop strain displays better results for averting dengue infections in the human population.
- Published
- 2021
- Full Text
- View/download PDF
18. Evaluation of a Wireless Home Sleep Monitoring System Compared to Polysomnography
- Author
-
Q. Pan, D. Brulin, E. Campo, Équipe Instrumentation embarquée et systèmes de surveillance intelligents (LAAS-S4M), Laboratoire d'analyse et d'architecture des systèmes (LAAS), Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse 1 Capitole (UT1), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse 1 Capitole (UT1), Université Fédérale Toulouse Midi-Pyrénées, Université Toulouse III - Paul Sabatier [UPS], Sciencesconf.org, CCSD, Université Toulouse Capitole (UT Capitole), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Université Toulouse Capitole (UT Capitole), and Université de Toulouse (UT)
- Subjects
wireless ,Biomedical Engineering ,Biophysics ,classification algorithm ,Sleep monitoring ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,[SPI.TRON] Engineering Sciences [physics]/Electronics ,[SPI.SIGNAL] Engineering Sciences [physics]/Signal and Image processing ,PSG ,[SPI.TRON]Engineering Sciences [physics]/Electronics - Abstract
International audience; Sleep is essential for human health. Bad sleep and sleepdisorders have been increasingly prevalent and are graduallybecoming a social problem that cannot be ignored. The currentgold standard in sleep monitoring is polysomnography (PSG)allowing nearly complete approach. Unfortunately, this wealthof information is obtained at the cost of invasive system, onlyusable in hospital environment under the control of sleepexperts. Therefore, we develop a wireless body networks forhome sleep monitoring with effort on non-intrusiveness,portability and autonomy. In this paper, we present our globalarchitecture from sensors to user display with a focus on mainfunctions and hardware. Then, we introduce the chosenindicators for sleep monitoring and the algorithms developedfor sleep stages classification. Finally we show the evaluationof our approach compared to PSG. We illustrate the sleep stageclassification during one night in the sleep unit of ToulouseUniversity Hospital and highlight correlation between bodytemperature on extremities and Periodic Limb Movementduring Sleep. Results are promising but need to be reinforcedwith new tests in hospital with several volunteers
- Published
- 2023
- Full Text
- View/download PDF
19. PEDIATRIC NODAL MARGINAL ZONE LYMPHOMA AND PEDIATRIC-TYPE FOLLICULAR LYMPHOMA SHARE A COMMON MOLECULAR PROFILE
- Author
-
J. Salmeron-Villalobos, C. Egan, V. Borgmann, I. Müller, B. Gonzalez-Farre, J. Ramis-Zaldivar, D. Nann, O. Balagué, M. Lopez-Guerra, D. Colomer, I. Oschlies, W. Klapper, S. Glaser, Y. Ko, I. Bonzheim, R. Siebert, F. Fend, S. Pittaluga, E. Campo, I. Salaverria, E. Jaffe, and L. Quintanilla-Martinez
- Subjects
Cancer Research ,Oncology ,Hematology - Published
- 2022
- Full Text
- View/download PDF
20. REFINING THE GENETIC LANDSCAPE OF AGGRESSIVE B-CELL LYMPHOMA BY INTEGRATIVE MOLECULAR ANALYSIS
- Author
-
S. Mato, J. Salmerón-Villalobos, N. Castrejón de Anta, J. Ramis-Zaldivar, N. Garcia, L. Wang, A. Colmenero, J. Verdú, M. Andrés, V. Celis, M. Ortega, E. Campo, O. Balagué, and I. Salaverria
- Subjects
Cancer Research ,Oncology ,Hematology - Published
- 2022
- Full Text
- View/download PDF
21. SOX11 AND EPSTEIN–BARR VIRUS MAY SUBSTITUTE EACH OTHER IN EARLY PATHOGENESIS OF BURKITT LYMPHOMA
- Author
-
M. Sureda-Gómez, I. Iaccarino, P. Balsas, J. Richter, S. Glaser, M. Rodríguez, A. De Bolòs, F. Nadeu, E. Campo, M. Siciliano, L. Leoncini, R. Siebert, W. Klapper, and V. Amador
- Subjects
Cancer Research ,Oncology ,Hematology - Published
- 2022
- Full Text
- View/download PDF
22. COVID-19, ferrosenescence and neurodegeneration, a mini-review
- Author
-
Michael Cummings, Jafri Afzaal, Adonis Sfera, Gerald A. Maguire, Jose E. Campo Maldonado, Carolina Osorio, and Leah Rahman
- Subjects
Coronavirus disease 2019 (COVID-19) ,Exacerbation ,medicine.medical_treatment ,Iron ,Disease ,Bioinformatics ,Virus ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Dipeptidyl peptidase-4 ,Cellular Senescence ,Biological Psychiatry ,Pharmacology ,business.industry ,Neurodegeneration ,COVID-19 ,Neurodegenerative Diseases ,Immunotherapy ,medicine.disease ,Phenotype ,Iron Metabolism Disorders ,030227 psychiatry ,business - Abstract
Exacerbation of cognitive, motor and nonmotor symptoms have been described in critically ill COVID-19 patients, indicating that, like prior pandemics, neurodegenerative sequelae may mark the aftermath of this viral infection. Moreover, SARS-CoV-2, the causative agent of COVID-19 disease, was associated with hyperferritinemia and unfavorable prognosis in older individuals, suggesting virus-induced ferrosenescence. We have previously defined ferrosenescence as an iron-associated disruption of both the human genome and its repair mechanisms, leading to premature cellular senescence and neurodegeneration. As viruses replicate more efficiently in iron-rich senescent cells, they may have developed the ability to induce this phenotype in host tissues, predisposing to both immune dysfunction and neurodegenerative disorders. In this mini-review, we summarize what is known about the SARS-CoV-2-induced cellular senescence and iron dysmetabolism. We also take a closer look at immunotherapy with natural killer cells, angiotensin II receptor blockers (“sartans”), iron chelators and dipeptidyl peptidase 4 inhibitors (“gliptins”) as adjunct treatments for both COVID-19 and its neurodegenerative complications., Graphical abstract SARS-CoV-2 exploitation of ACE-4, DPP4 and furin augment host intracellular iron, inflicting DNA and p53 damage, causing NK cells ferrosenescence. (CD147-induced mitochondrial damage and iron release are not shown). Disabled NKCs fail to clear senescent, virus-infected cells and α-synuclein, predisposing COVID-19 critical illness and neurodegenerative disorders.Unlabelled Image, Highlights • To proliferate in host cells, the SARS-CoV-2 virus requires iron. • To acquire iron and lower host immunity, the virus inflicts mitochondrial damage. • Iron-linked DNA, mtDNA and p53 disruption triggers ferrosenescence in NK cells. • Dysfunctional NK cells are incapable of eliminating senescent cells, leading to neurodegeneration. • Immunotherapy with NK cells and ferrosenescence-lowering drugs may facilitate the clearance of aged cells.
- Published
- 2021
- Full Text
- View/download PDF
23. TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: CLINICO‐BIOLOGICAL CHARACTERIZATION, EVALUATION OF TREATMENT RESPONSE AND SURVIVAL
- Author
-
J. Bosch, Pablo Mozas, T. Gustavo, Neus Villamor, G. Frigola, N. Kelleher, Ferran Nadeu, Silvia Martín, Laura Magnano, Alfredo Rivas-Delgado, Armando López-Guillermo, Tycho Baumann, Olga Balagué, Sílvia Beà, M. Grau, A. Muntañola, C. Barcena, A. Martín García-Sancho, Miguel Alcoceba, E. Campo, Cristina López, Fina Climent, Juan-Manuel Sancho, Eva González-Barca, Eva Giné, L. Luizaga, and Andrea Rivero
- Subjects
Cancer Research ,Treatment response ,Pathology ,medicine.medical_specialty ,Oncology ,business.industry ,medicine ,Hematology ,General Medicine ,medicine.disease ,business ,Diffuse large B-cell lymphoma - Published
- 2021
- Full Text
- View/download PDF
24. EFFICACY AND SAFETY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB AS FRONTLINE TREATMENT FOR INDOLENT CLINICAL FORMS OF MANTLE CELL LYMPHOMA. RESULTS OF THE GELTAMO IMCL‐2015 STUDY
- Author
-
Tomás José González-López, Eva González-Barca, A. Muntanola Prat, F. de la Cruz, J. López Jiménez, E. Campo, María José Casanova, Marta Aymerich, Alejandro Medina, M. J. Terol, A. Jiménez Ubieto, A. Martín García-Sancho, Eva Giné, Ramón García-Sanz, Xavier Setoain, Montserrat Cortés-Romera, A. Marín Niebla, Amanda Rotger, Armando López-Guillermo, and A. De la Fuente Burguera
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Hematology ,General Medicine ,medicine.disease ,chemistry.chemical_compound ,chemistry ,Internal medicine ,Ibrutinib ,medicine ,Rituximab ,Mantle cell lymphoma ,business ,medicine.drug - Published
- 2021
- Full Text
- View/download PDF
25. TRIPLE POSITIVE (CD10+BCL6+MUM1+) DIFFUSE LARGE B‐CELL LYMPHOMAS IN ADULTS ARE A HETEROGENEOUS GROUP ENRICHED IN LARGE B‐CELL LYMPHOMAS WITH IRF4 REARRANGEMENT
- Author
-
Leticia Quintanilla-Martinez, Irina Bonzheim, Julia Steinhilber, M. Pinyol, Franziska Otto, Barbara Mankel, Julia Salmeron-Villalobos, L. Rimza, Joan Enric Ramis-Zaldivar, Olga Balagué, Falko Fend, N. Castrejon‐de‐Anta, E. Campo, S. Streich, Itziar Salaverria, Leonie Frauenfeld, and Annika Katharina Mayer
- Subjects
Cancer Research ,medicine.anatomical_structure ,Heterogeneous group ,Oncology ,Chemistry ,medicine ,Hematology ,General Medicine ,Triple-Positive ,BCL6 ,Molecular biology ,B cell ,IRF4 - Published
- 2021
- Full Text
- View/download PDF
26. A SIMPLE EPIGENETIC SIGNATURE DEFINES TWO BIOLOGIC GROUPS OF MANTLE CELL LYMPHOMA
- Author
-
Marta Kulis, M. Duran‐Ferrer, Alfons Navarro, Ferran Nadeu, M. M. Bühler, J I Martín-Subero, Sílvia Beà, Eva Giné, Guillem Clot, Cristina López, and E. Campo
- Subjects
Cancer Research ,Oncology ,Simple (abstract algebra) ,medicine ,Mantle cell lymphoma ,Hematology ,General Medicine ,Epigenetics ,Computational biology ,Biology ,Signature (topology) ,medicine.disease - Published
- 2021
- Full Text
- View/download PDF
27. COVID-19: A Catalyst for Novel Psychiatric Paradigms - Part 1
- Author
-
Carolina Osorio, Aaron D. Chokka, Adonis Sfera, Zisis Kozlakidis, Jose E. Campo Maldonado, Carlos Manuel Zapata Martín del Campo, and Afzaal Jafri
- Subjects
0301 basic medicine ,03 medical and health sciences ,medicine.medical_specialty ,030104 developmental biology ,0302 clinical medicine ,Coronavirus disease 2019 (COVID-19) ,business.industry ,medicine ,Psychiatry ,business ,030217 neurology & neurosurgery - Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged in the late 2019 and spread rapidly throughout the world, becoming a pandemic in March 2020. It became obvious early that the prognosis of this illness is highly variable, ranging from few mild symptoms to severe complications and death, indicating that aside from the pathogen virulence, host factors contribute significantly to the overall outcome. Like SARS-CoV and Human Coronavirus NL63 (HCoV-NL63-NL63), SARS-CoV-2 enters host cells via several receptors among which angiotensin converting enzyme-2 (ACE-2) are the most studied. As this protein is widely expressed in the lungs, blood vessels, brain, kidney, testes and ovaries, the effects of this virus are widespread, affecting many body tissues and organs. Viral attachment to ACE-2 downregulates this protein, disrupting angiotensin II (ANG II) hydrolysis that in return contributes to the unchecked accumulation of this peptide. ANG II toxicity is the result of excessive activation of ANG II type 1 receptors (AT-1Rs) and N-methyl-D-aspartate NMDA receptors (NMDARs). Overstimulation of these proteins, along with the loss of angiotensin (1–7) (ANG 1–7), upregulates reactive oxygen species (ROS), inflicting end-organ damage (hit 1). However, a preexistent redox impairment may be necessary for the development of SARS-CoV-2 critical illness (hit 2). Here we propose a two-hit paradigm in which COVID-19 critical illness develops primarily in individuals with preexistent antioxidant dysfunction. Several observational studies are in line with the two hit model as they have associated poor COVID-19 prognosis with the hereditary antioxidant defects. Moreover, the SARS-CoV-2 interactome reveals that viral antigen NSP5 directly inhibits the synthesis of glutathione peroxidase (GPX), an antioxidant enzyme that along with glucose-6-phosphate dehydrogenase (G6PD) protect the body from oxidative damage. Indeed, individuals with G6PD deficiency have less favorable COVID-19 outcomes compared to the general population.
- Published
- 2021
28. Avances recientes en HIV/SIDA: Patogénesis, historia natural y carga viral
- Author
-
Rafael E Campo and Ernesto G Scerpella
- Subjects
HIV ,AIDS ,pathogenesis ,viral load ,Medicine - Abstract
Results of recent investigations have given us a new understanding of the pathogenesis of HIV infection. This findings provide us with a kinetic model of pathogenesis in which continuous, high-grade viral replication. This findings provide us with a kinetic model of pathogenesis in which continuous, high-grade viral replication is the principal force driving the destruction of CD4 lymphocytes. This knowledge will lead us to design better treatment strategies directed to curtail viral replication and prevent the emergence of viral resistance, and the use of combination antiretroviral therapy is a first example of these new strategies. The concept of viral load is introduced, and we discuss the usefulness of viral load in the clinical prognosis of this disease, and its use as an aid in the decision-making process when starling or mordifyng antiretroviral therapy in our patients. (Rev Med Hered 1996; 7: 182-188).
- Published
- 1996
29. Detection of social isolation based on meal-taking activity and mobility of elderly people living alone
- Author
-
G. Bouaziz, D. Brulin, H. Pigot, E. Campo, Sciencesconf.org, CCSD, Équipe Instrumentation embarquée et systèmes de surveillance intelligents (LAAS-S4M), Laboratoire d'analyse et d'architecture des systèmes (LAAS), Université Toulouse Capitole (UT Capitole), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Université de Toulouse (UT)-Institut National des Sciences Appliquées (INSA)-Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Université Toulouse Capitole (UT Capitole), Université de Toulouse (UT), DOmotique et informatique Mobile à l'Université de Sherbrooke (DOMUS), Département d'informatique [Sherbrooke] (UdeS), Faculté des sciences [Sherbrooke] (UdeS), Université de Sherbrooke (UdeS)-Université de Sherbrooke (UdeS)-Faculté des sciences [Sherbrooke] (UdeS), Université de Sherbrooke (UdeS)-Université de Sherbrooke (UdeS), Université Toulouse III - Paul Sabatier [UPS], Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse 1 Capitole (UT1), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut National des Sciences Appliquées - Toulouse (INSA Toulouse), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Toulouse - Jean Jaurès (UT2J)-Université Toulouse 1 Capitole (UT1), Université Fédérale Toulouse Midi-Pyrénées, Université Toulouse III - Paul Sabatier (UT3), and Université Toulouse - Jean Jaurès (UT2J)
- Subjects
Mobility ,Social isolation ,Biomedical Engineering ,Biophysics ,Meal taking activity ,[INFO]Computer Science [cs] ,Monitoring systems ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,[SPI.TRON] Engineering Sciences [physics]/Electronics ,[SPI.TRON]Engineering Sciences [physics]/Electronics ,[SPI.SIGNAL] Engineering Sciences [physics]/Signal and Image processing - Abstract
International audience; Objectives BackgroundSocial isolation is probably one of the most affected health outcomes in the elderly people, particularly those living alone, due to the COVID-19 pandemic. Therefore, we try to identify it by detecting changes in the elderly such as malnutrition and lack of mobility.Material and methodsThe system consists of two types of sensors installed at various locations in the user's home: Passive infrared (PIR) sensors and reed switch sensors. It was implemented for 15 days in the home of a 26-year-old student living alone, as a first step to later be deployed in the home of elderly people.ResultsOur study showed strong similarities between the activities detected by the algorithm and the real activity pattern of the interviewed individual. In addition, the system was able to identify two daily patterns (weekday and weekend) of the person as he is a student and is present in class during the week.ConclusionA system composed of low-cost, unobtrusive, non-intrusive and miniaturized sensors is able to detect meal-taking activity and mobility. These results are an intermediate step in assessing the potential risk of social isolation in older people living alone based on these ADLs.
- Published
- 2021
- Full Text
- View/download PDF
30. PATTERNS OF CHANGE IN TREATMENT, SURVIVAL, HISTOLOGICAL TRANSFORMATION, AND SECONDARY MALIGNANCIES OF FOLLICULAR LYMPHOMA OVER THE LAST 4 DECADES: A SINGLE CENTER EXPERIENCE
- Author
-
L. Veloza, Olga Balagué, Eva Giné, Andrea Rivero, Julio Delgado, Neus Villamor, Pablo Mozas, Laura Magnano, Alfredo Rivas-Delgado, E. Campo, Tycho Baumann, Armando López-Guillermo, Ferran Nadeu, and Blanca Gonzalez-Farre
- Subjects
Cancer Research ,Transformation (genetics) ,Oncology ,business.industry ,Follicular lymphoma ,Cancer research ,Medicine ,Hematology ,General Medicine ,business ,Single Center ,medicine.disease - Published
- 2019
- Full Text
- View/download PDF
31. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups
- Author
-
Kate Ridout, Maite Cabes, Dimitris Vavoulis, Richard S. Houlston, J I Martín-Subero, Ruth Clifford, David Bruce, Anna Schuh, Knight Sjl., Jenny C. Taylor, Adam Burns, E. Campo, David Bentley, Adele Timbs, Robert Månsson, Reem Alsolami, Pauline Robbe, Renée Beekman, Basile Stamatopoulos, Jennifer Becq, and Helene Dreau
- Subjects
0301 basic medicine ,Genetics ,0303 health sciences ,Cancer Research ,Cytidine deaminase activity ,Somatic hypermutation ,Locus (genetics) ,Cytidine deaminase ,Hematology ,Sciences bio-médicales et agricoles ,Biology ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Oncology ,Kataegis ,030220 oncology & carcinogenesis ,hemic and lymphatic diseases ,Original Article ,Copy-number variation ,Corrigendum ,IGHV@ ,Gene ,030304 developmental biology - Abstract
This corrects the article DOI: 10.1038/leu.2017.177., info:eu-repo/semantics/published
- Published
- 2017
32. Sampling artifacts in single-cell genomics cohort studies
- Author
-
E. Campo, Antonio Julià, Catia Moutinho, Domenica Marchese, Holger Heyn, José I. Martín-Subero, Gustavo Rodriguez-Esteban, Giovanni Iacono, Esteban Ballestar, Sara Marsal, Núria Palau, Marta Aymerich, Ramon Massoni-Badosa, Javier Rodríguez-Ubreva, Dolors Colomer, and Marta Kulis
- Subjects
0303 health sciences ,Computer science ,030302 biochemistry & molecular biology ,Cell ,RNA ,Sampling (statistics) ,Genomics ,Sample (statistics) ,Sampling artifacts ,Computational biology ,Biobank ,Chromatin ,03 medical and health sciences ,medicine.anatomical_structure ,Gene expression ,medicine ,030304 developmental biology - Abstract
Robust protocols and automation now enable large-scale single-cell RNA and ATAC sequencing experiments and their application on biobank and clinical cohorts. However, technical biases introduced during sample acquisition can hinder solid, reproducible results and a systematic benchmarking is required before entering large-scale data production. Here, we report the existence and extent of gene expression and chromatin accessibility artifacts introduced during sampling and identify experimental and computational solutions for their prevention.
- Published
- 2020
- Full Text
- View/download PDF
33. Wolbachia-based biocontrol for dengue reduction using dynamic optimization approach
- Author
-
Daiver Cardona-Salgado, Lilian S. Sepúlveda-Salcedo, Doris E. Campo-Duarte, Olga Vasilieva, and Elsevier
- Subjects
Biological pest control ,Population Replacement ,Control de vectores ,02 engineering and technology ,Aedes aegypti ,Biology ,01 natural sciences ,Optimal release program ,Dengue fever ,wMelPop strain ,0203 mechanical engineering ,Dengue - Control biológico ,Dengue - Biological control ,0103 physical sciences ,parasitic diseases ,Dengue transmission ,medicine ,010301 acoustics ,Dengue transmission model ,Applied Mathematics ,medicine.disease ,biology.organism_classification ,Virology ,Vector control ,Optimal control ,020303 mechanical engineering & transports ,Wolbachia-based biocontrol ,Modeling and Simulation ,Wolbachia ,Finite time - Abstract
Aedes aegypti females mosquitoes are the principal transmitters of dengue and other arboviral infections. In recent years, it was disclosed that, when deliberately infected with Wolbachia symbiont, this mosquito species loses its vectorial competence and becomes less capable of transmitting the virus to human hosts. Thanks to this important discovery, Wolbachia-based biocontrol is now accepted as an ecologically friendly and potentially cost-effective method for prevention and control of dengue and other arboviral infections. In this paper, we propose a dengue transmission model that accounts for the presence of wild Aedes aegypti females and those deliberately infected with wMelPop Wolbachia strain, which is regarded as the best blocker of dengue and other arboviral infections. However, wMelPop strain of Wolbachia considerably reduces the individual fitness of mosquitoes, what makes rather challenging to achieve the gradual extrusion of wild mosquitoes and ensure their posterior replacement by Wolbachia-carriers. Nonetheless, this obstacle have been overcome by employing the optimal control approach for design of specific intervention programs based on daily releases of Wolbachia-carrying mosquitoes. The resulting optimal release programs ensure the population replacement and eventual local extinction of wild mosquitoes in the finite time and also entail a significant reduction in the number of expected dengue infections among human hosts under the long-term settings.
- Published
- 2020
34. Metformin inhibits the inflammatory and oxidative stress response induced by skin UVB-irradiation and provides 4-hydroxy-2-nonenal and nitrotyrosine formation and p53 protein activation. [Carta]
- Author
-
Poliana Camila Marinello, Fernando Pinheiro de Souza-Neto, Rubens Cecchini, Eliana Maiten Cela, Daniel H González-Maglio, Gabriela Pasqual Melo, Leandra Zambeli Naira Ramalho, Valeria E. Campo, and Alessandra Lourenço Cecchini
- Subjects
Skin Neoplasms ,Carcinogenesis ,Ultraviolet Rays ,Dermatology ,Pharmacology ,medicine.disease_cause ,Biochemistry ,2-Nonenal ,RADIAÇÃO ULTRAVIOLETA ,chemistry.chemical_compound ,Mice ,medicine ,Animals ,Humans ,Uvb irradiation ,Molecular Biology ,Melanoma ,Skin ,Aldehydes ,Chemistry ,Nitrotyrosine ,Metformin ,Oxidative Stress ,Radiation Injuries, Experimental ,P53 protein ,Tyrosine ,Female ,Radiodermatitis ,Tumor Suppressor Protein p53 ,Oxidative stress ,medicine.drug ,DNA Damage - Published
- 2020
35. Inhaled molgramostim therapy in autoimmune pulmonary alveolar proteinosis
- Author
-
Trapnell, B.C. Inoue, Y. Bonella, F. Morgan, C. Jouneau, S. Bendstrup, E. Campo, I. Papiris, S.A. Yamaguchi, E. Cetinkaya, E. Ilkovich, M.M. Kramer, M.R. Veltkamp, M. Kreuter, M. Baba, T. Ganslandt, C. Tarnow, I. Waterer, G. Jouhikainen, T. IMPALA Trial Investigators
- Abstract
BACKGROUND Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by progressive surfactant accumulation and hypoxemia. It is caused by disruption of granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling, which pulmonary alveolar macrophages require to clear surfactant. Recently, inhaled GM-CSF was shown to improve the partial pressure of arterial oxygen in patients with aPAP. METHODS In a double-blind, placebo-controlled, three-group trial, we randomly assigned patients with aPAP to receive the recombinant GM-CSF molgramostim (300 μg once daily by inhalation), either continuously or intermittently (every other week), or matching placebo. The 24-week intervention period was followed by an open-label treatment-extension period. The primary end point was the change from baseline in the alveolar-arterial difference in oxygen concentration (A-aDo2) at week 24. RESULTS In total, 138 patients underwent randomization; 46 were assigned to receive continuous molgramostim, 45 to receive intermittent molgramostim, and 47 to receive placebo. Invalid A-aDo2 data for 4 patients (1 in each molgramostim group and 2 in the placebo group) who received nasal oxygen therapy during arterial blood gas measurement were replaced by means of imputation. For the primary end point - the change from baseline in the A-aDo2 at week 24 - improvement was greater among patients receiving continuous molgramostim than among those receiving placebo (-12.8 mm Hg vs. -6.6 mm Hg; estimated treatment difference, -6.2 mm Hg; P = 0.03 by comparison of least-squares means). Patients receiving continuous molgramostim also had greater improvement than those receiving placebo for secondary end points, including the change from baseline in the St. George's Respiratory Questionnaire total score at week 24 (-12.4 points vs. -5.1 points; estimated treatment difference, -7.4 points; P = 0.01 by comparison of least-squares means). For multiple end points, improvement was greater with continuous molgramostim than with intermittent molgramostim. The percentages of patients with adverse events and serious adverse events were similar in the three groups, except for the percentage of patients with chest pain, which was higher in the continuous-molgramostim group. CONCLUSIONS In patients with aPAP, daily administration of inhaled molgramostim resulted in greater improvements in pulmonary gas transfer and functional health status than placebo, with similar rates of adverse events. (Funded by Savara Pharmaceuticals; IMPALA ClinicalTrials.gov number, NCT02702180.). Copyright © 2020 Massachusetts Medical Society.
- Published
- 2020
36. Oral administration of Lipoteichoic acid from Lactobacillus rhamnosus GG overcomes UVB-induced immunosuppression and impairs skin tumor growth in mice
- Author
-
William J. Shufesky, Eliana Maiten Cela, Adrián Friedrich, Valeria E. Campo, Daniel Horacio Gonzalez Maglio, Mariela L. Paz, Juliana Leoni, Olga A. Tckacheva, Adriana T. Larregina, and Adrian E. Morelli
- Subjects
0301 basic medicine ,Lipopolysaccharides ,Skin Neoplasms ,medicine.medical_treatment ,Administration, Oral ,Dermatitis, Contact ,Mice ,0302 clinical medicine ,Oral administration ,Cell Movement ,Immunology and Allergy ,Lymph node ,Skin ,biology ,Lacticaseibacillus rhamnosus ,Immunosuppression ,purl.org/becyt/ford/3.1 [https] ,Phenotype ,Medicina Básica ,medicine.anatomical_structure ,Carcinoma, Squamous Cell ,purl.org/becyt/ford/3 [https] ,Female ,Lipoteichoic acid ,CIENCIAS MÉDICAS Y DE LA SALUD ,Ultraviolet Rays ,Immunology ,Inmunología ,Antineoplastic Agents ,DENDRITIC CELLS ,Article ,03 medical and health sciences ,Immune system ,Lactobacillus rhamnosus ,medicine ,Animals ,TOLERANCE ,Dendritic Cells ,biology.organism_classification ,PROBIOTICS ,Gastrointestinal Tract ,Mice, Inbred C57BL ,Teichoic Acids ,stomatognathic diseases ,030104 developmental biology ,UV RADIATION ,Cancer research ,Lymph Nodes ,030215 immunology ,Homing (hematopoietic) ,SKIN DISEASES - Abstract
There is increasing evidence of the relevant connection and regulation between the gut and skin immune axis. In fact, oral administration of lipoteichoic acid (LTA) from Lactobacillus rhamnosus GG (LGG) prevents the development of UV‐induced skin tumors in chronically exposed mice. Here we aim to evaluate whether this LTA is able to revert UV‐induced immunosuppression as a mechanism involved in its anti‐tumor effect and whether it has an immunotherapeutic effect against cutaneous squamous cell carcinoma. Using a mouse model of contact hypersensitivity, we demonstrate that LTA overcomes UV‐induced skin immunosuppression. This effect was in part achieved by modulating the phenotype of lymph node resident dendritic cells (DC) and the homing of skin migratory DC. Importantly, oral LTA reduced significantly the growth of established skin tumors once UV radiation was discontinued, demonstrating that it has a therapeutic, besides the already demonstrated preventive antitumor effect. The data presented here strongly indicates that oral administration of LTA represents a promising immunotherapeutic approach for different conditions in which the skin immune system is compromised. Fil: Friedrich, Adrián David. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina Fil: Campo, Valeria Evelyn. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina Fil: Cela, Eliana Maiten. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina Fil: Morelli, Adrian E.. University of Pittsburgh; Estados Unidos Fil: Shufesky, William J.. University of Pittsburgh; Estados Unidos Fil: Tckacheva, Olga A.. University of Pittsburgh; Estados Unidos Fil: Leoni, Juliana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina Fil: Paz, Mariela Laura. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina Fil: Larregina, Adriana T.. University of Pittsburgh; Estados Unidos Fil: Gonzalez Maglio, Daniel Horacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Estudios de la Inmunidad Humoral Prof. Ricardo A. Margni; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina
- Published
- 2019
37. Author response for 'Oral administration of Lipoteichoic acid from Lactobacillus rhamnosus GG overcomes UVB‐induced immunosuppression and impairs skin tumor growth in mice'
- Author
-
null Adrián D. Friedrich, null Valeria E. Campo, null Eliana M. Cela, null Adrian E. Morelli, null William J. Shufesky, null Olga A. Tckacheva, null Juliana Leoni, null Mariela L. Paz, null Adriana T. Larregina, and null Daniel H. González Maglio
- Published
- 2019
- Full Text
- View/download PDF
38. Author response for 'Oral administration of Lipoteichoic acid from Lactobacillus rhamnosus GG overcomes UVB‐induced immunosuppression and impairs skin tumor growth in mice'
- Author
-
Eliana Maiten Cela, William J. Shufesky, Juliana Leoni, Daniel Horacio Gonzalez Maglio, Mariela L. Paz, Adrian E. Morelli, Adriana T. Larregina, Olga A. Tckacheva, Adrián Friedrich, and Valeria E. Campo
- Subjects
Lactobacillus rhamnosus ,Oral administration ,medicine.medical_treatment ,Skin tumor ,medicine ,Immunosuppression ,Lipoteichoic acid ,Pharmacology ,Biology ,biology.organism_classification - Published
- 2019
- Full Text
- View/download PDF
39. GENE-EXPRESSION PROFILING PREDICTS DISEASE PROGRESSION IN FOLLICULAR LYMPHOMA
- Author
-
Armando López-Guillermo, Sarah Huet, David Gentien, E. Campo, A. Viari, Alexandra Traverse-Glehen, Luc Xerri, S. Boyault, Fabrice Jardin, Gilles Salles, A.L. Feldman, Brian K. Link, Laura Magnano, B. Tesson, James R. Cerhan, Corinne Haioun, E. Thomas, Jean-Philippe Jais, S. M. Ansell, Fritz Offner, Karin Tarte, Benoit Albaud, S. Hayette, P. Feugier, and Pauline Brice
- Subjects
Cancer Research ,business.industry ,Disease progression ,Follicular lymphoma ,Hematology ,General Medicine ,medicine.disease ,Gene expression profiling ,03 medical and health sciences ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,Medicine ,business ,030215 immunology - Published
- 2017
- Full Text
- View/download PDF
40. Optimal control approach for establishing wMelPop wolbachia infection among wild aedes aegypti populations
- Author
-
Doris E. Campo-Duarte, Daiver Cardona-Salgado, Mikhail Svinin, and Olga Vasilieva
- Subjects
Male ,0301 basic medicine ,Population Dynamics ,030231 tropical medicine ,Biological pest control ,Population Replacement ,Mosquito Vectors ,Aedes aegypti ,Biology ,Models, Biological ,Dengue fever ,Dengue ,Animals as carriers of disease ,03 medical and health sciences ,Human health ,0302 clinical medicine ,Aedes ,parasitic diseases ,medicine ,Animals ,Humans ,Computer Simulation ,Pest Control, Biological ,Sex-structured model ,WMelPop strain ,Host Microbial Interactions ,Applied Mathematics ,Minimum time ,fungi ,Computational Biology ,Mathematical Concepts ,Optimal release policies ,medicine.disease ,biology.organism_classification ,Agricultural and Biological Sciences (miscellaneous) ,Virology ,Optimal control ,Animales vectores ,030104 developmental biology ,Wolbachia-based biocontrol ,Modeling and Simulation ,Vector (epidemiology) ,bacteria ,Female ,Wolbachia - Abstract
Wolbachia-based biocontrol has recently emerged as a potential method for prevention and control of dengue and other vector-borne diseases. Major vector species, such as Aedes aegypti females, when deliberately infected with Wolbachia become less capable of getting viral infections and transmitting the virus to human hosts. In this paper, we propose an explicit sex-structured population model that describes an interaction of uninfected (wild) male and female mosquitoes and those deliberately infected with wMelPop strain of Wolbachia in the same locality. This particular strain of Wolbachia is regarded as the best blocker of dengue and other arboviral infections. However, wMelPop strain of Wolbachia also causes the loss of individual fitness in Aedes aegypti mosquitoes. Our model allows for natural introduction of the decision (or control) variable, and we apply the optimal control approach to simulate wMelPop Wolbachia infestation of wild Aedes aegypti populations. The control action consists in continuous periodic releases of mosquitoes previously infected with wMelPop strain of Wolbachia in laboratory conditions. The ultimate purpose of control is to find a tradeoff between reaching the population replacement in minimum time and with minimum cost of the control effort. This approach also allows us to estimate the number of Wolbachia-carrying mosquitoes to be released in day-by-day control action. The proposed method of biological control is safe to human health, does not contaminate the environment, does not make harm to non-target species, and preserves their interaction with mosquitoes in the ecosystem.
- Published
- 2018
41. MUTATIONAL LANDSCAPE OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS
- Author
-
N. Villamor, Silvia Martín, Alfredo Rivas-Delgado, Julio Delgado, Miguel Osuna, Ferran Nadeu, Pablo Mozas, Eva Giné, Anna Enjuanes, Tycho Baumann, Olga Balagué, A. Lopez-Guillermo, Catrejon N. de Anta, Laura Magnano, and E. Campo
- Subjects
Circulating tumor DNA ,medicine ,Cancer research ,Hematology ,Primary mediastinal B-cell lymphoma ,Biology ,medicine.disease - Published
- 2019
- Full Text
- View/download PDF
42. GENOME WIDE-ANALYSIS OF T(14;18)-NEGATIVE FOLLICULAR LYMPHOMA
- Author
-
Irina Bonzheim, Julia Salmeron-Villalobos, Janine Schmidt, Elaine S. Jaffe, Caoimhe Egan, Joan Enric Ramis-Zaldivar, Itziar Salaverria, A. Chott, Inga Müller, Christiane Copie-Bergman, L. Quintanilla de Fend, Blanca Gonzalez-Farre, Stefan Dojcinov, Vanessa Szablewski, E. Campo, Falko Fend, and Sven Mattern
- Subjects
Cancer Research ,Oncology ,Genome wide analysis ,Follicular lymphoma ,medicine ,Cancer research ,Hematology ,General Medicine ,Biology ,medicine.disease - Published
- 2019
- Full Text
- View/download PDF
43. PF522 MUTATIONAL LANDSCAPE OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS
- Author
-
Silvia Martín, A. Lopez-Guillermo, Miguel Osuna, N. Villamor, N. Catrejon de Anta, Ferran Nadeu, Olga Balagué, Tycho Baumann, E. Campo, Eva Giné, Julio Delgado, Pablo Mozas, Anna Enjuanes, Laura Magnano, and Alfredo Rivas-Delgado
- Subjects
Circulating tumor DNA ,medicine ,Cancer research ,Hematology ,Primary mediastinal B-cell lymphoma ,Biology ,medicine.disease - Published
- 2019
- Full Text
- View/download PDF
44. MUTATIONAL LANDSCAPE OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT DIAGNOSIS AND AT PROGRESSION ASSESSED BY CIRCULATING TUMOR DNA ANALYSIS
- Author
-
Armando López-Guillermo, E. Campo, Pablo Mozas, Olga Balagué, Alfredo Rivas-Delgado, Anna Enjuanes, N. Castrejón de Anta, Eva Giné, Ferran Nadeu, Julio Delgado, Laura Magnano, Neus Villamor, and Tycho Baumann
- Subjects
Cancer Research ,Oncology ,Circulating tumor DNA ,Cancer research ,medicine ,Hematology ,General Medicine ,Biology ,medicine.disease ,Diffuse large B-cell lymphoma - Published
- 2019
- Full Text
- View/download PDF
45. DECIPHERING THE CONTRIBUTION OF MACROPHAGES TO FOLLICULAR LYMPHOMA PATHOGENESIS: NEW INSIGHTS INTO THERAPY
- Author
-
Silvia Martín, E. Campo, Juan G. Valero, P. Perez Galan, Fabian Arenas, Alfredo Rivas-Delgado, Anella Yahiaoui, Stacey Tannheimer, Maria C. Cid, Joaquim Carreras, Armando López-Guillermo, V. Rodriguez, M. Corbera, Neus Serrat, Dolors Colomer, Alba Matas-Céspedes, and Martina Guerrero-Hernández
- Subjects
Pathogenesis ,Cancer Research ,Oncology ,business.industry ,Follicular lymphoma ,Cancer research ,Medicine ,Hematology ,General Medicine ,business ,medicine.disease - Published
- 2019
- Full Text
- View/download PDF
46. PS1147 SPATIAL HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKAEMIA ANALYSED BY WHOLE-GENOME/EXOME SEQUENCING AT DIAGNOSIS
- Author
-
Xose S. Puente, David Torrents, F. Maura, Julio Delgado, Romina Royo, M. Aymerich, E. Campo, Ferran Nadeu, M. Pinyol, K.J. Dawson, Sílvia Beà, A. Dueso, and A. Lopez-Guillermo
- Subjects
Lymphocytic leukaemia ,Hematology ,Computational biology ,Biology ,Genome ,Exome sequencing ,Spatial heterogeneity - Published
- 2019
- Full Text
- View/download PDF
47. GENOTYPING PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS
- Author
-
Armando López-Guillermo, Silvia Martín, Tycho Baumann, Anna Enjuanes, Olga Balagué, Julio Delgado, Ferran Nadeu, N. Castrejón de Anta, Eva Giné, Neus Villamor, E. Campo, Laura Magnano, Pablo Mozas, Alfredo Rivas-Delgado, and Miguel Osuna
- Subjects
Cancer Research ,Oncology ,Circulating tumor DNA ,business.industry ,medicine ,Cancer research ,Hematology ,General Medicine ,Primary mediastinal B-cell lymphoma ,medicine.disease ,business ,Genotyping - Published
- 2019
- Full Text
- View/download PDF
48. SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6
- Author
-
Daniel Martinez, Virginia Amador, Álvaro Eguileor, Maria Carmela Vegliante, Jara Palomero, Patricia Balsas, Marta Leonor Rodríguez, and E. Campo
- Subjects
0301 basic medicine ,Cancer Research ,Lymphoma, Mantle-Cell ,Biology ,SOXC Transcription Factors ,Fusion gene ,03 medical and health sciences ,0302 clinical medicine ,immune system diseases ,Cell Line, Tumor ,hemic and lymphatic diseases ,Transcriptional regulation ,medicine ,Humans ,Regulation of gene expression ,Genetics ,Hematology ,medicine.disease ,BCL6 ,Lymphoma ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Proto-Oncogene Proteins c-bcl-6 ,Cancer research ,Mantle cell lymphoma ,Stem cell - Abstract
SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6
- Published
- 2015
- Full Text
- View/download PDF
49. Book Reviews
- Author
-
Amanda Luyster, Alex J. Novikoff, Juan E. Campo, Barbara Brend, Leslie Peirce, and Rose Aslan
- Subjects
Urban Studies ,Visual Arts and Performing Arts ,Architecture ,Geography, Planning and Development - Published
- 2015
- Full Text
- View/download PDF
50. Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphoma
- Author
-
Dolors Costa, Kennosuke Karube, Dolors Colomer, Julio Delgado, M. Pinyol, Alejandra Martínez-Trillos, Eva Giné, Jordina Rovira, Laura Magnano, Blanca Gonzalez-Farre, E. Campo, Armando López-Guillermo, Alfredo Rivas-Delgado, Neus Villamor, A. Martínez-Pozo, Olga Balagué, and Ivan Dlouhy
- Subjects
Oncology ,Male ,medicine.medical_specialty ,Cell of origin ,Follicular lymphoma ,03 medical and health sciences ,Transformed Lymphoma ,0302 clinical medicine ,immune system diseases ,hemic and lymphatic diseases ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,Humans ,Single institution ,neoplasms ,Lymphoma, Follicular ,Aged ,Performance status ,business.industry ,Hematology ,medicine.disease ,Prognosis ,Lymphoma ,Survival Rate ,030220 oncology & carcinogenesis ,Case-Control Studies ,Rituximab ,Female ,Lymphoma, Large B-Cell, Diffuse ,Neoplasm Recurrence, Local ,business ,Diffuse large B-cell lymphoma ,030215 immunology ,medicine.drug ,Follow-Up Studies - Abstract
Background The co-existence at diagnosis of follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) components (FL/DLBCL) has been considered a transformed lymphoma and accordingly treated although clinicobiological information on these patients is scarce. The aim of this study was to analyze the initial features and outcome of FL/DLBCL patients in the rituximab era. Patients and methods All patients consecutively diagnosed at a single institution with FL/DLBCL (n = 40), as well as those with pure FL (n = 328) or de novo DLBCL (n = 510) as controls. Results The proportion of the DLBCL component was highly variable (median 50%). In 29 FL/DLBCL cases analyzed, the cell of origin was GCB in 86%, ABC in 10% and unclassifiable in 4%. NOTCH1-2 was mutated in 10% of these cases. The proportion of DLBCL component did not impact on overall survival (OS). Regarding initial characteristics, patients with FL/DLBCL were closer to FL in terms of primary nodal origin, good performance status and advanced stage, whereas the other features were intermediate between FL and DLBCL. FL/DLBCL patients were treated as DLBCL with no further intensification. Complete response and primary refractory rates were 65% and 20%, respectively, with these figures being similar to DLBCL and worse than FL. Progression-free survival and OS were intermediate between FL and DLBCL (5-year OS: 85%, 73% and 63% for FL, FL/DLBCL and DLBCL, respectively). FL/DLBCL histology did not reach independent prognostic value for OS in the multivariate analyses. Conclusions The outcome of FL/DLBCL patients is not worse than that of de novo DLBCL. These cases should be treated with immunochemotherapy as DLBCL, but intensification with ASCT may not be necessary. The biological insights of FL/DLBCL warrants further genetic and molecular studies.
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.